Dr Daniel Levi Willis, MD - Medicare Urology in Bend, OR

Dr Daniel Levi Willis, MD is a medicare enrolled "Urology" physician in Bend, Oregon. He went to Virginia Commonwealth University, School Of Medicine and graduated in 2007 and has 17 years of diverse experience with area of expertise as Urology. He is a member of the group practice Bend Memorial Clinic Pc and his current practice location is 2090 Ne Wyatt Ct Ste 101, Bend, Oregon. You can reach out to his office (for appointments etc.) via phone at (541) 382-6447.

Dr Daniel Levi Willis is licensed to practice in Oregon (license number MD208021) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1023211547.

Contact Information

Dr Daniel Levi Willis, MD
2090 Ne Wyatt Ct Ste 101,
Bend, OR 97701-7691
(541) 382-6447
Not Available



Physician's Profile

Full NameDr Daniel Levi Willis
GenderMale
SpecialityUrology
Experience17 Years
Location2090 Ne Wyatt Ct Ste 101, Bend, Oregon
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Daniel Levi Willis attended and graduated from Virginia Commonwealth University, School Of Medicine in 2007
  NPI Data:
  • NPI Number: 1023211547
  • Provider Enumeration Date: 06/11/2007
  • Last Update Date: 01/24/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 5496908840
  • Enrollment ID: I20220117000623

Medical Identifiers

Medical identifiers for Dr Daniel Levi Willis such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1023211547NPI-NPPES
311365601MedicaidTX
8DQ392OtherTXBCBS

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208800000XUrology P3486 (Texas)Secondary
208800000XUrology TRN10996 (Florida)Secondary
208800000XUrology MD208021 (Oregon)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
St Charles Home Health ServicesBend, ORHome health agency
St Charles Medical Center - BendBend, ORHospital
St Charles PrinevillePrineville, ORHospital
Blue Mountain HospitalJohn day, ORHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Bend Memorial Clinic Pc7214936533201

News Archive

R-Tech Ueno, Sucampo Pharmaceuticals request arbitration against Takeda Pharmaceutical

R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and Sucampo. On March 12, 2010, Sucampo submitted for filing with the International Court of Arbitration, International Chamber of Commerce, a Request for Arbitration against Takeda. In that Request, Sucampo claimed that Takeda has violated the provisions of the October 29, 2004, Collaboration and License Agreement between Sucampo and Takeda and other applicable duties, and that Takeda's violations have injured Sucampo. Sucampo requested all appropriate relief, including termination of the agreements, damages remedy and so on.

Cyclist pollution exposure minimized by use of quieter roads

Research suggests that using quieter streets with less traffic exposes city cyclists to lower levels of air pollution than using more congested routes, although wind-speed has a significant influence on levels of pollution exposure experienced each day.

Neurosurgeons remove hypothalamic hamartoma to combat hyperphagia, unhealthy weight gain

Neurosurgeons at the University of Texas-Houston and Children's Memorial Hermann Hospital (Houston, Texas) report on the success they achieved when they removed a hypothalamic hamartoma from a 10-year-old girl to combat hyperphagia (excessive appetite and compulsive overeating) and consequent unhealthy weight gain.

Macchiarini scandal leads to weakening of confidence in medical research among Swedish public

The scandal surrounding the surgeon Paolo Macchiarini has led to a fall in confidence in medical research among one third of the Swedish public, who are familiar with the incidents.

RXi Pharmaceuticals receives Notice of Allowance from USPTO for novel, self-delivering RNAi platform

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering and developing innovative therapeutics, primarily in the areas of dermatology and ophthalmology, today announced that it received a Notice of Allowance from the United States Patent and Trademark Office on its novel, self-delivering RNAi platform (sd‑rxRNA).

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Daniel Levi Willis allows following entities to bill medicare on his behalf.
Entity NameBend Memorial Clinic Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1699827477
PECOS PAC ID: 7214936533
Enrollment ID: O20061215000022

News Archive

R-Tech Ueno, Sucampo Pharmaceuticals request arbitration against Takeda Pharmaceutical

R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and Sucampo. On March 12, 2010, Sucampo submitted for filing with the International Court of Arbitration, International Chamber of Commerce, a Request for Arbitration against Takeda. In that Request, Sucampo claimed that Takeda has violated the provisions of the October 29, 2004, Collaboration and License Agreement between Sucampo and Takeda and other applicable duties, and that Takeda's violations have injured Sucampo. Sucampo requested all appropriate relief, including termination of the agreements, damages remedy and so on.

Cyclist pollution exposure minimized by use of quieter roads

Research suggests that using quieter streets with less traffic exposes city cyclists to lower levels of air pollution than using more congested routes, although wind-speed has a significant influence on levels of pollution exposure experienced each day.

Neurosurgeons remove hypothalamic hamartoma to combat hyperphagia, unhealthy weight gain

Neurosurgeons at the University of Texas-Houston and Children's Memorial Hermann Hospital (Houston, Texas) report on the success they achieved when they removed a hypothalamic hamartoma from a 10-year-old girl to combat hyperphagia (excessive appetite and compulsive overeating) and consequent unhealthy weight gain.

Macchiarini scandal leads to weakening of confidence in medical research among Swedish public

The scandal surrounding the surgeon Paolo Macchiarini has led to a fall in confidence in medical research among one third of the Swedish public, who are familiar with the incidents.

RXi Pharmaceuticals receives Notice of Allowance from USPTO for novel, self-delivering RNAi platform

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering and developing innovative therapeutics, primarily in the areas of dermatology and ophthalmology, today announced that it received a Notice of Allowance from the United States Patent and Trademark Office on its novel, self-delivering RNAi platform (sd‑rxRNA).

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Daniel Levi Willis is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Daniel Levi Willis, MD
Po Box 6048,
Bend, OR 97708-6048

Ph: (541) 382-4900
Dr Daniel Levi Willis, MD
2090 Ne Wyatt Ct Ste 101,
Bend, OR 97701-7691

Ph: (541) 382-6447

News Archive

R-Tech Ueno, Sucampo Pharmaceuticals request arbitration against Takeda Pharmaceutical

R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and Sucampo. On March 12, 2010, Sucampo submitted for filing with the International Court of Arbitration, International Chamber of Commerce, a Request for Arbitration against Takeda. In that Request, Sucampo claimed that Takeda has violated the provisions of the October 29, 2004, Collaboration and License Agreement between Sucampo and Takeda and other applicable duties, and that Takeda's violations have injured Sucampo. Sucampo requested all appropriate relief, including termination of the agreements, damages remedy and so on.

Cyclist pollution exposure minimized by use of quieter roads

Research suggests that using quieter streets with less traffic exposes city cyclists to lower levels of air pollution than using more congested routes, although wind-speed has a significant influence on levels of pollution exposure experienced each day.

Neurosurgeons remove hypothalamic hamartoma to combat hyperphagia, unhealthy weight gain

Neurosurgeons at the University of Texas-Houston and Children's Memorial Hermann Hospital (Houston, Texas) report on the success they achieved when they removed a hypothalamic hamartoma from a 10-year-old girl to combat hyperphagia (excessive appetite and compulsive overeating) and consequent unhealthy weight gain.

Macchiarini scandal leads to weakening of confidence in medical research among Swedish public

The scandal surrounding the surgeon Paolo Macchiarini has led to a fall in confidence in medical research among one third of the Swedish public, who are familiar with the incidents.

RXi Pharmaceuticals receives Notice of Allowance from USPTO for novel, self-delivering RNAi platform

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering and developing innovative therapeutics, primarily in the areas of dermatology and ophthalmology, today announced that it received a Notice of Allowance from the United States Patent and Trademark Office on its novel, self-delivering RNAi platform (sd‑rxRNA).

Read more News

› Verified 5 days ago


Urology Doctors in Bend, OR

Dr. Matt S Ashley, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 2090 Ne Wyatt Ct Ste 101, Bend, OR 97701
Phone: 541-382-6447    Fax: 541-330-7413
Andrew David Neeb, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 431 Ne Revere Ave Ste 200, Bend, OR 97701
Phone: 541-508-7973    Fax: 541-508-7968
Hagop Sarkissian, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 2090 Ne Wyatt Ct Ste 101, Bend, OR 97701
Phone: 541-382-6447    
Dr. Meredith Rae Baker, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 2090 Ne Wyatt Ct, Suite 101, Bend, OR 97701
Phone: 541-382-6447    Fax: 541-330-7413
Dr. Michel Adeodat Boileau, MD
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 2090 Ne Wyatt Ct, Suite 101, Bend, OR 97701
Phone: 541-382-6447    Fax: 541-330-7413
Dr. Jack Alan Brewer, MD
Urology
Medicare: Medicare Enrolled
Practice Location: 2090 Ne Wyatt Ct, Suite 101, Bend, OR 97701
Phone: 541-382-6447    Fax: 541-330-7413

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.